Multiple Myeloma Studied in New Mouse Model Developed at Yale
Understanding how multiple myeloma develops and responds to therapies may be easier using a new mouse model developed at Yale University School of Medicine. The model supports…
News
WT1 Vaccine Helped High-Risk Multiple Myeloma Patients After Stem Cell Transplant
High-risk multiple myeloma patients may benefit markedly from galinpepimut-S, an experimental immunotherapy from SELLAS Life Sciences, following autologous stem cell transplant (ASCT), according to recent…
UV Light Robots Reduced Hospital-Acquired Infections by 25%, Study Finds
Robots can do all sorts of tasks to improve cancer treatment and now researchers have added room cleaning to the list. Indeed, Robots that use…
FDA Grants Priority Review to Darzalex Combo Therapy for Relapsed Multiple Myeloma Patients
The U.S. Food and Drug Administration (FDA) is giving priority review to a supplemental Biologics License Application (sBLA) to approve Genmab‘s Darzalex (…
Study Furthers Knowledge of How Multiple Myeloma Cells Take Hold in Bone Marrow
The communication between multiple myeloma cells and healthy bone marrow cells is an important step in disease progression, researchers have found, showing that multiple myeloma…
MMRF Opening Wealth of Myeloma Genomic Data to Researchers via NCI
The Multiple Myeloma Research Foundation (MMRF) is going to add its entire worth of genomic data to the Genomic Data Commons, a National Cancer…
Kyprolis Combo Fails to Outperform Velcade for Multiple Myeloma Patients Newly Diagnosed
Treatment of newly diagnosed multiple myeloma patients with a combination of Kyprolis (carfilzomib), Alkeran (melphalan), and prednisone does not yield superior outcomes, compared to the triple combination of Velcade…
BioInvent Gets New Patent Protections for BI-505 as Possible Multiple Myeloma Treatment
BioInvent International has received further patent protection in China, Japan, and Russia covering the use of BI-505 in cancer patients who have failed to respond…
Statin Use May Improve Survival in Newly Diagnosed Multiple Myeloma Patients
Newly diagnosed multiple myeloma patients who are using statins have lower mortality rates than those who don’t, a large population-based cohort study reported. In the study,…
PharmaMar Seeks EU Approval for Aplidin to Treat Multiple Myeloma
PharmaMar has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for the use of Aplidin (plitidepsin) in combination with Decadron (dexamethasone, an…
